WHO Approves Two New Drug to Treat COVID-19

Category : International Published on: January 17 2022

Share on facebook

The World Health Organization has approved two new drugs for two new COVID-19 treatments that will help expand its arsenal of vaccines as well as tools to prevent serious illness and virus deaths.
These two drug are baricitinib and casirivimab-imdevimab.
The WHO has recommended Eli Lilly & Co.’s rheumatoid arthritis drug and GlaxoSmithKline Plc’s monoclonal antibody.
Lilly's baricitinib drug is a Janus kinase (JAK) inhibitor- a class of drugs used to treat autoimmune conditions, blood and bone marrow cancers, and rheumatoid arthritis.